Science & Enterprise subscription

Follow us on Twitter

  • A New England hospital system is assessing with real patients a point-of-care test for Covid-19 viruses that return… https://t.co/kdaawxTrOU
    about 7 hours ago
  • New post on Science and Enterprise: Hospitals Testing Fast Covid-19 Diagnostic https://t.co/Ou6Fk0L4Yb #Science #Business
    about 7 hours ago
  • Results of a clinical trial show contact lenses that focus light on multiple areas of the retina reduce near-sighte… https://t.co/fJkqvINR8w
    about 14 hours ago
  • New post on Science and Enterprise: Muti-Focus Contact Lenses Slow Children’s Myopia https://t.co/mWV1LNbHOW #Science #Business
    about 14 hours ago
  • Could?? ... How Russia’s Rushed Covid-19 Vaccine Could Backfire https://t.co/Sqt4P3jllE
    about 17 hours ago

Please share Science & Enterprise

Foundations Direct $5M for Neurodegenerative Tests

Brain cell networks

Two foundations are spending $5 million to develop new diagnostics for frontotemporal degeneration, an inherited neurodegenerative disorder and form of dementia. . . . → Read More: Foundations Direct $5M for Neurodegenerative Tests

Start-Up Analyzes Images to Determine Medical Condition

Stewart Wang

A new company provides a service that determines a person’s condition for disease treatments based on indicators derived from an analysis of huge medical-image databases. . . . → Read More: Start-Up Analyzes Images to Determine Medical Condition

FDA Approves 25 Precision Meds in 2018

Onpattro

An organization advocating for medicines addressing a person’s unique chemical composition rather than disease symptoms says U.S. regulators approved 25 of those drugs in 2018. . . . → Read More: FDA Approves 25 Precision Meds in 2018

Trial Testing Breath Detection for Cancer

Breath collection device

A clinical trial is recruiting participants to test a technology that analyzes exhaled breath for indicators of specific types of cancer. . . . → Read More: Trial Testing Breath Detection for Cancer

FDA Approves Biomarker-Targeting Cancer Drug

DNA methylation illustration

The Food and Drug Administration yesterday approved a treatment for solid tumor cancers that focuses on specific cancer-causing genetic conditions rather than location of the cancer in the body. . . . → Read More: FDA Approves Biomarker-Targeting Cancer Drug

Gates, Lauder Backing Early Alzheimer’s Biomarker Tests

Brain circuits

A group of well-known philanthropists is backing a new research program to find simple tests that reveal early indicators of Alzheimer’s disease in a person’s molecular make-up. . . . → Read More: Gates, Lauder Backing Early Alzheimer’s Biomarker Tests

Immune Disease Precision Therapy Company Starts Up

An enterprise to discover biomarkers and precise treatments for individuals with immune system disorders is starting up, founded by six researchers in the U.S. and Europe. . . . → Read More: Immune Disease Precision Therapy Company Starts Up

FDA Clears First Blood Test for Concussions

The Food and Drug Administration authorized for marketing in the U.S. a blood test that screens for chemical indicators in the blood for concussions, a form of traumatic brain injury. . . . → Read More: FDA Clears First Blood Test for Concussions

Report: 19 New Precision Medicines Approved in 2017

A report on Food and Drug Administration approvals of new therapies says the agency is accelerating its reviews of treatments designed to address the specific molecular composition of individuals. . . . → Read More: Report: 19 New Precision Medicines Approved in 2017

Microsoft Providing A.I. for Big Data Cancer Research

Seven research teams are receiving grants to study complex problems in cancer immunotherapy with large-scale data sets, and assistance with machine learning and artificial intelligence provided by Microsoft Corp. . . . → Read More: Microsoft Providing A.I. for Big Data Cancer Research